Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
An aortic vascular surgery case being performed with the Philips LumiGuide FORS system. The light-based technology enables catheter navigation and the ability to see the catheters in multiple views with out the need for X-ray imaging in the cath lab.

Philips launches new light-based, radiation-free cath lab imaging system

LumiGuide uses fiber optic realShape (FORS) technology, where light is reflected along an optical fiber inside a guidewire to generate 3D, high-resolution, color images of devices inside a patient’s body

February 22, 2024
Alain Cribier, MD, a veteran interventional cardiologist known for performing the very first transcatheter aortic valve replacement (TAVR), died on Feb. 16. He was 79 years old.

Cardiology pioneer, known for performing world’s first TAVR, remembered as a ‘true visionary’

Alain Cribier, MD, a veteran interventional cardiologist out of France, died at the age of 79. The procedure he helped put on the map is arguably cardiology's most significant breakthrough in the last several decades. 

February 22, 2024
An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Illinois cardiologist not held responsible for patient's death while waiting for angiogram

A judge upheld a previous trial victory that cleared Prairie Cardiovascular Consults of alleged mishandling of a patient and not fully understanding the severity of the heart condition prior to their death.

February 21, 2024
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.

Implementing a same-day PCI discharge pathway boils down to correct patient selection

Safety is key to which individuals are selected for SDD, and there can be benefits to both patients and health systems as this becomes the predominant model of care in elective PCI.

February 20, 2024
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.

Anticoagulants after TAVR: 5-year survival data favor DOACs over VKAs

However, that one finding does not tell the whole story. Researchers also found that DOACs may increase a TAVR patient's risk of a disabling stroke.

February 15, 2024
Surender Malhotra, MD, an interventional cardiologist with Fairview Park Hospital in Dublin, Georgia, is back on the job after losing his right arm in a near-fatal accident.

Georgia cardiologist treating heart patients again after losing arm in accident

A veteran interventional cardiologist lost his right arm in an accident, but did not let that stop him from returning to his patients. 

February 14, 2024
doctor looking at CLTI patient's leg

FDA grants bioresorbable scaffold system its breakthrough device designation to treat infrapopliteal lesions

The new drug-eluting device was designed to provide both stability and flexibility to patients presenting with below-the-knee lesions.  

February 14, 2024
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA advisory panel votes in favor of Abbott’s TriClip device for tricuspid regurgitation

After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks. 

February 14, 2024
Displaying 89 - 96 of 1435

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup